Azithromycin, RECOVERY, and the power of large, simple trials
- PMID: 33545097
- PMCID: PMC7906649
- DOI: 10.1016/S0140-6736(21)00307-X
Azithromycin, RECOVERY, and the power of large, simple trials
Comment on
-
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. Lancet. 2021. PMID: 33545096 Free PMC article. Clinical Trial.
References
-
- Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stat Med. 1984;3:409–422. - PubMed
-
- Bauchner H, Fontanarosa PB. Randomized clinical trials and COVID-19: managing expectations. JAMA. 2020;323:2262–2263. - PubMed
-
- RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19—preliminary report. N Engl J Med. 2020 https://www.nejm.org/doi/full/10.1056/NEJMoa2021436 published online July 17. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
